Omid Nikpayam

1.2k total citations
37 papers, 919 citations indexed

About

Omid Nikpayam is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Omid Nikpayam has authored 37 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 13 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Pharmacology. Recurrent topics in Omid Nikpayam's work include Diet and metabolism studies (10 papers), Natural Antidiabetic Agents Studies (9 papers) and Coffee research and impacts (4 papers). Omid Nikpayam is often cited by papers focused on Diet and metabolism studies (10 papers), Natural Antidiabetic Agents Studies (9 papers) and Coffee research and impacts (4 papers). Omid Nikpayam collaborates with scholars based in Iran, United States and Australia. Omid Nikpayam's co-authors include Golbon Sohrab, Mehdi Hedayati, Meghdad Sedaghat, Azita Hekmatdoost, Neda Roshanravan, Reyhaneh Yousefi, Atoosa Saidpour, Gity Sotoudeh, Alireza Ostadrahimi and Arman Ghorbani and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal Of Nutrition and Phytotherapy Research.

In The Last Decade

Omid Nikpayam

35 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omid Nikpayam Iran 16 263 217 205 200 180 37 919
Marilisa Bove Italy 19 249 0.9× 183 0.8× 179 0.9× 235 1.2× 110 0.6× 41 1.1k
Golbon Sohrab Iran 21 358 1.4× 278 1.3× 384 1.9× 219 1.1× 236 1.3× 55 1.3k
Mitra Hariri Iran 23 275 1.0× 360 1.7× 186 0.9× 431 2.2× 210 1.2× 69 1.6k
Vali Musazadeh Iran 21 177 0.7× 314 1.4× 177 0.9× 277 1.4× 63 0.3× 75 1.0k
Iraj Heydari Iran 14 148 0.6× 137 0.6× 143 0.7× 166 0.8× 58 0.3× 32 595
Hossein Rafiei Canada 18 147 0.6× 233 1.1× 93 0.5× 278 1.4× 68 0.4× 35 880
Naseh Pahlavani Iran 24 120 0.5× 210 1.0× 186 0.9× 201 1.0× 27 0.1× 70 1.2k
Kylie Abbott Australia 15 105 0.4× 220 1.0× 224 1.1× 119 0.6× 72 0.4× 25 638
David Briskey Australia 22 109 0.4× 342 1.6× 111 0.5× 392 2.0× 46 0.3× 53 1.1k
Zahra Yari Iran 23 455 1.7× 430 2.0× 156 0.8× 426 2.1× 146 0.8× 93 1.6k

Countries citing papers authored by Omid Nikpayam

Since Specialization
Citations

This map shows the geographic impact of Omid Nikpayam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omid Nikpayam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omid Nikpayam more than expected).

Fields of papers citing papers by Omid Nikpayam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omid Nikpayam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omid Nikpayam. The network helps show where Omid Nikpayam may publish in the future.

Co-authorship network of co-authors of Omid Nikpayam

This figure shows the co-authorship network connecting the top 25 collaborators of Omid Nikpayam. A scholar is included among the top collaborators of Omid Nikpayam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omid Nikpayam. Omid Nikpayam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Behrouz, Vahideh, et al.. (2024). What are the effects of crocin supplementation on lipid profile and oxidative stress in patients with type 2 diabetes? A randomized clinical trial. Journal of Functional Foods. 121. 106396–106396. 1 indexed citations
4.
Musazadeh, Vali, et al.. (2024). The effect of glucomannan supplementation on lipid profile in adults: a GRADE-assessed systematic review and meta-analysis. BMC Cardiovascular Disorders. 24(1). 545–545. 4 indexed citations
5.
6.
Faghfouri, Amir Hossein, et al.. (2023). The effect of low-fructose diet on anthropometric and metabolic factors: A systematic review and meta-analysis. Nutrition Metabolism and Cardiovascular Diseases. 34(2). 281–293. 5 indexed citations
8.
Fakhri, Farima, et al.. (2023). Is vitamin D deficiency associated with retinopathy in type 2 diabetes mellitus? A case-control study. Clinical Nutrition ESPEN. 59. 158–161. 4 indexed citations
9.
Naghsh, Navid, Vali Musazadeh, Omid Nikpayam, et al.. (2023). Profiling Inflammatory Biomarkers following Curcumin Supplementation: An Umbrella Meta‐Analysis of Randomized Clinical Trials. Evidence-based Complementary and Alternative Medicine. 2023(1). 4875636–4875636. 15 indexed citations
10.
Rahimi, Fatemeh, Yahya Pasdar, Mojtaba Kaviani, et al.. (2022). Efficacy of the Synbiotic Supplementation on the Metabolic Factors in Patients with Metabolic Syndrome: A Randomized, Triple‐Blind, Placebo‐Controlled Trial. International Journal of Clinical Practice. 2022(1). 2967977–2967977. 8 indexed citations
11.
Nikpayam, Omid, et al.. (2021). A comprehensive insight into the potential effects of resveratrol supplementation on SIRT-1: A systematic review. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 15(5). 102224–102224. 15 indexed citations
12.
Mobasseri, Majid, Alireza Ostadrahimi, Samira Asghari, et al.. (2020). Effects of saffron supplementation on glycemia and inflammation in patients with type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical trial study. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 14(4). 527–534. 48 indexed citations
13.
Nikpayam, Omid, et al.. (2020). The effect of green coffee extract supplementation on lipid profile: A systematic review of clinical trial and in-vivo studies. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 14(5). 1521–1528. 2 indexed citations
14.
Behrouz, Vahideh, et al.. (2020). Effects of low fructose diet on glycemic control, lipid profile and systemic inflammation in patients with type 2 diabetes: A single-blind randomized controlled trial. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 14(5). 849–855. 13 indexed citations
15.
Ghaedi, Ehsan, et al.. (2019). Effects of probiotics and synbiotic supplementation on antioxidant status: A meta-analysis of randomized clinical trials. Clinical Nutrition ESPEN. 30. 81–88. 38 indexed citations
18.
Nikpayam, Omid, Mohammad Hossein Rouhani, Makan Pourmasoumi, et al.. (2018). The Effect of Pycnogenol Supplementation on Plasma C-Reactive Protein Concentration: a Systematic Review and Meta-Analysis. Clinical Nutrition Research. 7(2). 117–117. 10 indexed citations
19.
Mirmiran, Parvin, et al.. (2018). The barberry juice effects on metabolic factors and oxidative stress in patients with type 2 diabetes: A randomized clinical trial. Complementary Therapies in Clinical Practice. 31. 170–174. 50 indexed citations
20.
Sohrab, Golbon, Javad Nasrollahzadeh, Maryam Tohidi, Hamid Zand, & Omid Nikpayam. (2018). Pomegranate Juice Increases Sirtuin1 Protein in Peripheral Blood Mononuclear Cell from Patients with Type 2 Diabetes: A Randomized Placebo Controlled Clinical Trial. Metabolic Syndrome and Related Disorders. 16(8). 446–451. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026